FDA Inspection
BloodworksBloodworks – FDA Inspection, Oct 26, 2010
Record Details
This FDA Inspection record concerns Bloodworks, with an inspection on October 26, 2010, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Bloodworks
- Inspection Date
- October 26, 2010
- Product Type
- Biologics
View Company Profile
ID · d69123ad-0f6d-404e-b5ce-12a1c31f41e3
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 696654
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
3- 21 CFR 606.160(b)Required records
- 21 CFR 640.25(a)Storage temps./agitation
- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Bloodworks
8| Date | Classification | Office | Project area |
|---|---|---|---|
| April 8, 2026 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 9, 2022 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 18, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 26, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 5, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Bloodworks
- FDA Inspection 1312306 - 2026-04-08
- FDA Inspection 1190669 - 2022-11-09
- FDA Inspection 1097659 - 2019-07-18
- FDA Inspection 983200 - 2016-08-26
- FDA Inspection 894094 - 2014-09-05
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.